Characteristics of systemic and topical agents implicated in toxicity of the middle and inner ear

Ear, Nose and Throat Journal

Volumn 82, Issue 1 SUPPL., 2003, Pages 3-8

  Roland, Peter S ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPHOTERICIN B; ANTINEOPLASTIC AGENT; AZITHROMYCIN; BACITRACIN; CARBENICILLIN; CHLORAMPHENICOL; CISPLATIN; CLARITHROMYCIN; ERYTHROMYCIN; ETACRYNIC ACID; FUROSEMIDE; GENTAMICIN; KANAMYCIN; LOOP DIURETIC AGENT; MACROLIDE; NONSTEROID ANTIINFLAMMATORY AGENT; NYSTATIN; POLYMYXIN B; QUININE; SALICYLIC ACID; STREPTOMYCIN; TETRACYCLINE; TIMENTIN; TOBRAMYCIN; UNINDEXED DRUG; VANCOMYCIN; VINBLASTINE; VINCRISTINE;

AUDIOMETRY; CLINICAL TRIAL; CONFERENCE PAPER; DOSE RESPONSE; DRUG MECHANISM; DRUG MEGADOSE; EDEMA; EPIDEMIOLOGICAL DATA; HEARING LOSS; HUMAN; INNER EAR; LEG CRAMP; MEDICOLEGAL ASPECT; MIDDLE EAR; NONHUMAN; OTOTOXICITY; PERCEPTION DEAFNESS; RISK FACTOR; STRIA VASCULARIS; VESTIBULAR DISORDER;

EID: 0037244094     PISSN: 01455613     EISSN: None     Source Type: Journal    
DOI: 10.1177/014556130308201s02     Document Type: Conference Paper

References (17)

1. Schweitzer VG. Ototoxicity of chemotherapeutic agents. Otolaryngol Clin North Am 1993;26:759-89.
2. Jung TT, Rhee CK, Lee CS, et al. Ototoxicity of salicylate, nonsteroidal antiinflammatory drugs, and quinine. Otolaryngol Clin North Am 1993;26:791-810.
3. Govaerts PJ, Claes J, van de Heyning PH, et al. Aminoglycoside-induced ototoxicity. Toxicol Lett 1990;52:227-51.
4. Fausti SA, Henry JA, Schaffer HI, et al. High-frequency audiometric monitoring for early detection of aminoglycoside ototoxicity. J Infect Dis 1992;165:1026-32.
5. Black FO, Gianna-Poulin C, Pesznecker SC. Recovery from vestibular ototoxicity. Otol Neurotol 2001;22:662-71.
6. Nakashima T, Teranishi M, Hibi T, et al. Vestibular and cochlear toxicity of aminoglycosides-a review. Acta Otolaryngol 2000; 120:904-11.
7. Lim DJ. Effects of noise and ototoxic drugs at the cellular level in the cochlea: A review. Am J Otolaryngol 1986;7:73-99.
8. Minor LB. Gentamicin-induced bilateral vestibular hypofunction. JAMA 1998;279:541-4.
9. Fischel-Ghodsian N, Prezant TR, Chaltraw WE, et al. Mitochondrial gene mutation is a significant predisposing factor in amino-glycoside ototoxicity. Am J Otolaryngol 1997;18:173-8.
10. Halmagyi GM, Fattore CM, Curthoys IS, Wade S. Gentamicin vestibulotoxicity. Otolaryngol Head Neck Surg 1994;111:371-4.
11. Parker FL, James GW. The effect of various topical antibiotic and antibacterial agents on the middle and inner ear of the guinea pig. J Pharm Pharmacol 1978;30:236-9.
12. Brown OE, Wright CG, Masaki M, Meyerhoff WL. Ototoxicity of Vasocidin drops applied to the chinchilla middle ear. Arch Otolaryngol Head Neck Surg 1988;114:56-9.
13. Aursnes J. Vestibular damage from chlorhexidine in guinea pigs. Acta Otolaryngol 1981;92:89-100.
14. Tom LW. Ototoxicity of common topical antimycotic preparations. Laryngoscope 2000;110:509-16.
15. Schacht J. Antioxidant therapy attenuates aminoglycoside-induced hearing loss. Ann N Y Acad Sci 1999;884:125-30.
16. Sinswat P, Wu WJ, Sha SH, Schacht J. Protection from ototoxicity of intraperitoneal gentamicin in guinea pig. Kidney Int 2000; 58:2525-32.
17. Conlon BJ, Smith DW. Topical aminoglycoside ototoxicity: Attempting to protect the cochlea. Acta Otolaryngol 2000;120: 596-9.